1 – 10 of 46
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study
(
- Contribution to journal › Article
-
Mark
Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials
(
- Contribution to journal › Article
- 2012
-
Mark
A Randomized, Double-Blind, Placebo-Controlled Study of Single Dose Rituximab as Induction in Renal Transplantation: A 3-Year Follow-Up
(
- Contribution to journal › Letter
-
Mark
First global forum on education on organ donation and transplantation for schools.
2012) In Pediatric Transplantation(
- Contribution to journal › Article
-
Mark
Immunosuppressive properties of a series of novel inhibitors of the monocarboxylate transporter MCT-1.
2012) In Transplant international : official journal of the European Society for Organ Transplantation(
- Contribution to journal › Article
-
Mark
Challenges and considerations in diagnosing the kidney disease in deteriorating graft function.
2012) In Transplant international : official journal of the European Society for Organ Transplantation 25(11). p.1119-1128(
- Contribution to journal › Article
- 2011
-
Mark
Relationship of Tacrolimus Exposure and Mycophenolate Mofetil Dose With Renal Function After Renal Transplantation.
(
- Contribution to journal › Article
- 2010
-
Mark
Authors' Reply to Letter by van den Hoogen and Hilbrands
(
- Contribution to journal › Letter
-
Mark
Effect of Triple Costimulation Blockade on Islet Allograft Survival in Sensitized Mice
2010) Joint Meeting of the International-Pancreas-and-Islet-Transplant-Association/International-Xe notransplantation-Association 42(6). p.2109-2111(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Is Rituximab Safe to Use in Kidney Transplant Patients?
(
- Contribution to journal › Letter